Backstrom T., et al. Mood, sexuality, hormones and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosomatic Medicine, 1983; 45:503–507.
Baerwald A. R., Adams G. P., Pierson R. A. A new model for ovarian follicular development during the human menstrual cycle. Fertil. Steril., 2003; 80:116–122.
Bagga D., et al. Effects of a very low fat, high fiber diet on serum hormones and menstrual function: implications for breast cancer prevention. Cancer, 1995; 76:2491–2496.
Bahat A., et al. Thermotaxis of mammalian sperm cells: A potential navigation mechanism in the female genital tract. Nature Med., 2003; 9:149–150.
Baird D. D., et al. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites. Epidemiology, 1995; 6:547–550.
Baird D. D., et al. Using the ratio of urinary oestrogen and progesterone metabolites to estimate day of ovulation. Stat. Med., 1991; 10:255–266.
Bakker G. H., et al. Treatment of breast cancer with different antiprogestins: preclinical and clinical studies. Journal of Steroid Biochemistry and Molecular Biology, 1990; 37:789–794.
Bakos O., et al. Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle. Acta Obstet. Gynecol. Scand. 1994; 73:790–796.
Balasch J. Sex steroids and bone: current perspectives. Hum. Reprod. Update, 2003; 9:207–222.
Baldi E., et al. Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. J. Androl. 1991; 12:323–330.
Baldi E., et al. Nongenomic activation of spermatozoa by steroid hormones: facts and fictions. Mol. Cell Endocrinol., 2009; 308:39–46.
Baldi E., et al. Progesterone and spermatozoa: a long-lasting liaison comes to definition. Human Reproduction, 2011; 26 (11):2933–2934.
Ball B., Miller P., Daels P. Influence of exogenous progesterone on early embryonic development in the mare. Theriogenology, 1992; 38:1055–1063.
Baranczuk R. J., Fainstat T. Progesterone-induced ovulation of the hamster ovary in vitro. J. Endocrinol., 1976; 70:317–318.
Barnard K., et al. Health status among women with menstrual symptoms. Journal of Women’s Health, 2003; 12:911–919.
Barron A. M., Pike C. Sex hormones, aging, and Alzheimer’s disease. Front Biosci (Elite Ed), 2013; 4:976–997.
Baruffi R., et al. Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates. J. Assist. Reprod. Genet., 2003; 20:517–520.
Baskin L. S., Himes K., Colborn T. Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect, 2001; 109:1175–1183.
Bayard F., et al. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J. Clin. Endocrinol. Metab., 1978; 46:635–648.
Bazer F. W., et al. Select nutrients, progesterone, and interferon tau affect conceptus metabolism and development. Ann. NY Acad. Sci., 2012; 1271:88–96.
Bazer F. W., Slayden O. D. Progesterone-induced gene expression in uterine epithelia: a myth perpetuated by conventional wisdom. Biol. Reprod., 2008; 79,1008–1009.
Beckmann M. W. et al. Influence of steroid hormones on 5 alpha-reductase activity in female and male genital skin fibroblasts in culture. Acta Endocrinol. (Copenh), 1993; 128:161–167.
Bedford J. M. Site of the mammalian sperm physiological acrosome reaction. Proc. Natl. Acad. Sci., USA, 2011; 108:4703–4704.
Bedu-Addo, et al. Mobilisation of stored calcium in the neck region of human sperm — a mechanism for regulation of flagellar activity. Int. J. Dev. Biol., 2008; 52:615–626.
Beir H. M. A hormone-sensitive endometrial protein in blastocysts development. Biochim. Biophys. Acta, 1968; 160:239–291.
Beleut M., et al. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc. Natl. Acad. Sci., USA, 2010; 107:2989–2994.
Benagiano G., Bastianelli C., Farris M. Selective progesterone receptor modulators: use in oncology, endocrinology and psychiatry. Expert Opinion on Pharmacotherapy, 2008; 9:2487–2496.
Beral V., Bull D., Reeves G. Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet, 2005; 365:1543–1551.
Beral V. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet, 2003; 362:419–427.
Beral V. Million Women Study Collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet, 2007; 369:1703–1710.
Bercovici J. P., Darragon T. Administration route of natural sex steroids (estradiol, progesterone, testosterone). Nouv Presse Med., 1980; 9:179–183.
Berga S., Naftolin F. Neuroendocrine control of ovulation. Gynecol. Endocrinol., 2012; 28 (S (1)):9–13.
Bergeron C. Morphological changes and protein secretion induced by progesterone in the endometrium during the luteal phase in preparation for nidation. Hum. Reprod., 2000;15:119–128.